bromocriptine has been researched along with metformin in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (21.05) | 29.6817 |
| 2010's | 14 (73.68) | 24.3611 |
| 2020's | 1 (5.26) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bjerve, KS; Carlsen, SM; Kjøtrød, SB; Maesel, A; Vanky, E | 1 |
| Stanosz, S | 1 |
| Falbo, A; Palomba, S; Zullo, F | 1 |
| Cahyanur, R; Purnamasari, D; Setyawan, W; Setyowati, S; Soewondo, P; Sudrajat, DG | 1 |
| Kopecky, C | 1 |
| Garg, SK; Michels, AW; Shah, VN | 1 |
| Krysiak, R; Okopien, B; Okrzesik, J | 2 |
| Chamarthi, B; Raskin, P; Roe, ED | 1 |
| Gilowski, W; Krysiak, R; Okopien, B; Szkrobka, W | 1 |
| Chamarthi, B; Cincotta, AH; Ezrokhi, M; Rutty, D | 1 |
| Chamarthi, B; Cincotta, AH | 1 |
| Bao, X; Deng, K; Feng, M; Gao, J; Liu, X; Liu, Y; Wang, R; Yao, Y | 1 |
| Bao, X; Deng, K; Feng, M; Gao, J; Han, G; Lian, W; Liu, X; Liu, Y; Lv, X; Wang, R; Xing, B; Yao, Y | 1 |
| Bloomgarden, Z; Cao, M | 1 |
4 review(s) available for bromocriptine and metformin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Management strategies for ovulation induction in women with polycystic ovary syndrome and known clomifene citrate resistance.
Topics: Acetylcysteine; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Bromocriptine; Clomiphene; Dexamethasone; Drug Resistance; Female; Fertility Agents, Female; Free Radical Scavengers; Glucocorticoids; Gonadotropin-Releasing Hormone; Gonadotropins; Hormone Antagonists; Humans; Hypoglycemic Agents; Infertility, Female; Laparoscopy; Metformin; Naltrexone; Narcotic Antagonists; Octreotide; Ovary; Ovulation Induction; Polycystic Ovary Syndrome | 2009 |
Use of noninsulin antidiabetic medications in hospitalized patients.
Topics: Benzamides; Biguanides; Bromocriptine; Diabetes Mellitus; Dipeptidyl-Peptidase IV Inhibitors; Glycoside Hydrolase Inhibitors; Hospitalization; Humans; Hypoglycemia; Hypoglycemic Agents; Incretins; Islet Amyloid Polypeptide; Metformin; Sulfonylurea Compounds; Thiazolidinediones | 2013 |
Use of non-insulin therapies for type 1 diabetes.
Topics: Allylamine; Animals; Blood Glucose; Bromocriptine; Cardiovascular Diseases; Colesevelam Hydrochloride; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Dipeptidyl-Peptidase IV Inhibitors; Gastrins; Glucagon-Like Peptide 1; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Islet Amyloid Polypeptide; Leptin; Metformin; Sodium-Glucose Transporter 1; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Sulfonylurea Compounds; Thiazolidinediones; United States | 2013 |
4 trial(s) available for bromocriptine and metformin
| Article | Year |
|---|---|
Dexamethasone reduces androgen levels in metformin-treated patients with polycystic ovary syndrome.
Topics: Androgens; Antineoplastic Agents, Hormonal; Blood Glucose; Bromocriptine; Dexamethasone; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypoglycemic Agents; Life Style; Metformin; Placebos; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin; Time Factors | 2004 |
The Effect of Atorvastatin on Cardiometabolic Risk Factors in Bromocriptine-Treated Premenopausal Women with Isolated Hypercholesterolemia.
Topics: Adult; Atorvastatin; Bromocriptine; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, LDL; Diabetes Mellitus, Type 2; Diet; Dopamine Agonists; Exercise; Female; Fibrinogen; Homocysteine; Humans; Hypercholesterolemia; Hyperprolactinemia; Hypoglycemic Agents; Hypolipidemic Agents; Metformin; Middle Aged; Premenopause; Risk Factors; Uric Acid | 2015 |
Impact of bromocriptine-QR therapy on cardiovascular outcomes in type 2 diabetes mellitus subjects on metformin.
Topics: Aged; Blood Glucose; Bromocriptine; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Dopamine Agonists; Double-Blind Method; Drug Therapy, Combination; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Kaplan-Meier Estimate; Male; Metformin; Middle Aged; Risk Factors | 2016 |
Effect of bromocriptine-QR therapy on glycemic control in subjects with type 2 diabetes mellitus whose dysglycemia is inadequately controlled on insulin.
Topics: Adult; Aged; Aged, 80 and over; Bromocriptine; Diabetes Mellitus, Type 2; Dopamine Agonists; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Male; Metformin; Middle Aged; Treatment Outcome | 2017 |
11 other study(ies) available for bromocriptine and metformin
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
An attempt at conservative treatment in selected cases of type I endometrial carcinoma (stage I a/G1) in young women.
Topics: Adult; Bromocriptine; Dilatation and Curettage; Endometrial Neoplasms; Endometrium; Estriol; Female; Humans; Metformin; Progesterone; Young Adult | 2009 |
Diagnosis and management of acromegaly: giant invasive adenoma.
Topics: Acromegaly; Bromocriptine; Follicle Stimulating Hormone; Growth Hormone; Hormone Antagonists; Humans; Hypoglycemic Agents; Insulin-Like Growth Factor I; Luteinizing Hormone; Magnetic Resonance Imaging; Male; Metformin; Middle Aged; Pituitary Neoplasms | 2011 |
The effect of short-term metformin treatment on plasma prolactin levels in bromocriptine-treated patients with hyperprolactinaemia and impaired glucose tolerance: a pilot study.
Topics: Adult; Bromocriptine; Dopamine Agonists; Female; Glucose Intolerance; Humans; Hyperprolactinemia; Hypoglycemic Agents; Metformin; Pilot Projects; Prolactin | 2015 |
Impact of Bromocriptine-QR Therapy on Glycemic Control and Daily Insulin Requirement in Type 2 Diabetes Mellitus Subjects Whose Dysglycemia Is Poorly Controlled on High-Dose Insulin: A Pilot Study.
Topics: Adult; Aged; Blood Glucose; Bromocriptine; Diabetes Mellitus, Type 2; Dopamine Agonists; Female; Humans; Hypoglycemic Agents; Insulin; Male; Metformin; Middle Aged; Pilot Projects; Treatment Outcome | 2015 |
Different Effects of Metformin on the Hypothalamic-Pituitary-Thyroid Axis in Bromocriptine- and Cabergoline-treated Patients with Hashimoto's Thyroiditis and Glucose Metabolism Abnormalities.
Topics: Adult; Bromocriptine; Cabergoline; Ergolines; Female; Glucose Metabolism Disorders; Hashimoto Disease; Humans; Hypothalamo-Hypophyseal System; Metformin; Middle Aged; Thyroid Gland | 2015 |
Combination Treatment with Bromocriptine and Metformin in Patients with Bromocriptine-Resistant Prolactinomas: Pilot Study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bromocriptine; Female; Humans; Male; Metformin; Pituitary Neoplasms; Prolactin; Prolactinoma | 2018 |
Metformin inhibits growth and prolactin secretion of pituitary prolactinoma cells and xenografts.
Topics: AMP-Activated Protein Kinase Kinases; Animals; Apoptosis; Bromocriptine; Cell Proliferation; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Heterografts; Humans; Metformin; Mice; Phosphorylation; Pituitary Diseases; Prolactin; Prolactinoma; Protein Kinases; Receptors, Dopamine D2 | 2018 |
New insights into the older hypoglycemic agents in type 2 diabetes therapy.
Topics: Acarbose; Blood Glucose; Bromocriptine; Cardiovascular Diseases; Colesevelam Hydrochloride; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Metformin; Sulfonylurea Compounds; Thiazolidinediones; Treatment Outcome | 2020 |